Cosmos Health Inc. (NASDAQ:COSM) Short Interest Up 102.5% in June

Cosmos Health Inc. (NASDAQ:COSM) was the recipient of a significant growth in short interest during the month of June. As of June 30th, there was short interest totaling 4,744,953 shares, a growth of 102.5% from the June 15th total of 2,343,632 shares. Based on an average daily trading volume, of 15,984,868 shares, the days-to-cover ratio is presently 0.3 days. Approximately 10.3% of the shares of the company are short sold.

Insider Transactions at Cosmos Health

In related news, CEO Grigorios Siokas acquired 218,447 shares of the stock in a transaction on Thursday, June 11th. The shares were acquired at an average price of $0.21 per share, for a total transaction of $45,873.87. Following the transaction, the chief executive officer owned 13,481,808 shares in the company, valued at approximately $2,831,179.68. This trade represents a 1.65% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Georgios Terzis acquired 168,135 shares of the company’s stock in a transaction dated Tuesday, June 16th. The shares were purchased at an average cost of $0.25 per share, for a total transaction of $42,033.75. Following the purchase, the chief financial officer directly owned 2,235,398 shares in the company, valued at approximately $558,849.50. This trade represents a 8.13% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders bought 1,088,029 shares of company stock worth $249,240 in the last 90 days. Company insiders own 26.15% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Citadel Advisors LLC boosted its holdings in Cosmos Health by 133.1% in the 3rd quarter. Citadel Advisors LLC now owns 225,507 shares of the company’s stock worth $250,000 after buying an additional 128,776 shares during the last quarter. Renaissance Technologies LLC raised its holdings in shares of Cosmos Health by 260.5% during the fourth quarter. Renaissance Technologies LLC now owns 334,575 shares of the company’s stock valued at $167,000 after acquiring an additional 241,775 shares during the last quarter. Finally, XTX Topco Ltd lifted its position in shares of Cosmos Health by 52.1% in the fourth quarter. XTX Topco Ltd now owns 99,610 shares of the company’s stock valued at $50,000 after acquiring an additional 34,117 shares in the last quarter. 12.61% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Cosmos Health in a report on Monday, June 15th. One research analyst has rated the stock with a Sell rating, According to MarketBeat, Cosmos Health currently has an average rating of “Sell”.

Cosmos Health Price Performance

NASDAQ COSM traded down $0.02 on Wednesday, hitting $0.29. The company had a trading volume of 4,132,757 shares, compared to its average volume of 4,609,426. The company has a market capitalization of $18.06 million, a PE ratio of -0.45 and a beta of 4.83. The company’s fifty day moving average price is $0.25 and its 200-day moving average price is $0.35. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.08 and a quick ratio of 0.92. Cosmos Health has a 12-month low of $0.16 and a 12-month high of $1.32.

Cosmos Health (NASDAQ:COSM) last posted its quarterly earnings data on Wednesday, May 20th. The company reported ($0.06) earnings per share for the quarter, hitting analysts’ consensus estimates of ($0.06). Cosmos Health had a negative net margin of 30.41% and a negative return on equity of 52.85%. The company had revenue of $18.40 million during the quarter, compared to analysts’ expectations of $17.93 million. As a group, analysts predict that Cosmos Health will post -0.06 earnings per share for the current year.

About Cosmos Health

Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies and independent specialty distributors.